Medical research

The potential and challenges of mucosal COVID-19 vaccines

In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2. The highlights of this workshop ...

Diseases, Conditions, Syndromes

Study finds RSV may evade vaccines via rapid mutation

For most people, respiratory syncytial virus (RSV) is about as dangerous as the common cold. But for children younger than six months old, and for people whose immune defenses have been weakened by age, disease, chemotherapy ...

page 12 from 40